全文获取类型
收费全文 | 2114篇 |
免费 | 278篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 31篇 |
儿科学 | 81篇 |
妇产科学 | 30篇 |
基础医学 | 436篇 |
口腔科学 | 47篇 |
临床医学 | 226篇 |
内科学 | 451篇 |
皮肤病学 | 29篇 |
神经病学 | 129篇 |
特种医学 | 132篇 |
外科学 | 206篇 |
综合类 | 53篇 |
一般理论 | 1篇 |
预防医学 | 212篇 |
眼科学 | 34篇 |
药学 | 205篇 |
中国医学 | 5篇 |
肿瘤学 | 93篇 |
出版年
2022年 | 11篇 |
2021年 | 41篇 |
2019年 | 21篇 |
2018年 | 23篇 |
2017年 | 16篇 |
2016年 | 33篇 |
2015年 | 40篇 |
2014年 | 49篇 |
2013年 | 74篇 |
2012年 | 105篇 |
2011年 | 78篇 |
2010年 | 57篇 |
2009年 | 71篇 |
2008年 | 78篇 |
2007年 | 101篇 |
2006年 | 92篇 |
2005年 | 91篇 |
2004年 | 79篇 |
2003年 | 94篇 |
2002年 | 85篇 |
2001年 | 63篇 |
2000年 | 59篇 |
1999年 | 71篇 |
1998年 | 59篇 |
1997年 | 58篇 |
1996年 | 48篇 |
1995年 | 33篇 |
1994年 | 42篇 |
1993年 | 42篇 |
1992年 | 54篇 |
1991年 | 46篇 |
1990年 | 32篇 |
1989年 | 39篇 |
1988年 | 47篇 |
1987年 | 27篇 |
1986年 | 49篇 |
1985年 | 32篇 |
1984年 | 29篇 |
1983年 | 22篇 |
1982年 | 22篇 |
1981年 | 19篇 |
1980年 | 23篇 |
1979年 | 24篇 |
1978年 | 28篇 |
1977年 | 12篇 |
1976年 | 19篇 |
1974年 | 21篇 |
1973年 | 27篇 |
1972年 | 12篇 |
1970年 | 10篇 |
排序方式: 共有2401条查询结果,搜索用时 0 毫秒
41.
Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes 总被引:5,自引:0,他引:5
Stafforini DM McIntyre TM Zimmerman GA Prescott SM 《Critical reviews in clinical laboratory sciences》2003,40(6):643-672
Platelet-activating factor (PAF) is a potent proinflammatory phospholipid with diverse pathological and physiological effects. This bioactive phospholipid mediates processes as diverse as wound healing, physiological inflammation, apoptosis, angiogenesis, reproduction and long-term potentiation. Recent progress has demonstrated the participation of MAP kinase signaling pathways as modulators of the two critical enzymes, phospholipase A2 and acetyltransferase, involved in the remodeling pathway of PAF biosynthesis. The unregulated production of structural analogs of PAF by non-specific oxidative reactions has expanded this superfamily of signaling molecules to include "PAF-like" lipids whose mode of action is identical to that of authentic PAF. The action of members of this family is mediated by the PAF receptor, a G protein-coupled membrane-spanning molecule that can engage multiple signaling pathways in various cell types. Inappropriate activation of this signaling pathway is associated with many diseases in which inflammation is thought to be one of the underlying features. Inactivation of all members of the PAF superfamily occurs by a unique class of enzymes, the PAF acetylhydrolases, that have been characterized at the molecular level and that terminate signals initiated by both regulated and unregulated PAF production. 相似文献
42.
Temporal artery biopsy is considered the gold standard investigation of giant cell arteritis and is recommended in suspected cases despite a sensitivity of 81–91%. This review highlights the potential risk of facial nerve injury during temporal artery biopsy and introduces recent advances in the emerging role of imaging modalities. When these non-invasive techniques are used in conjunction with American College of Rheumatology scoring, which includes clinical features and biochemical test results, temporal artery biopsy may be avoided in selected cases. 相似文献
43.
J Isherwood G Garcea R Williams M Metcalfe AR Dennison 《Annals of the Royal College of Surgeons of England》2014,96(3):224-228
Introduction
Magnetic resonance cholangiopancreatography (MRCP) is not a routine investigation to exclude choledocholithiasis unless there is clinical or biochemical suspicion of common bile duct (CBD) stones. This study attempted to determine which radiological or serological parameters best predicted CBD stones.Methods
All patients undergoing MRCP from 2005 to 2011 were selected. Patients with pancreatitis were excluded. Liver function tests (LFTs) at admission and prior to MRCP were recorded, as was abdominal ultrasonography and MRCP results. Parameters measured routinely on LFTs included alkaline phosphatase (ALP), alanine transaminase (ALT) and bilirubin. Receiver operating characteristic curve area analysis (area under the curve [AUC]) and chi-squared analysis were undertaken.Results
Overall, 195 patients were identified, 71 of whom had CBD stones on MRCP. Raised ALP levels on admission demonstrated a correlation with CBD stones (AUC: 0.619, odds ratio [OR]: 3.16, p=0.06). At ultrasonography, a dilated CBD (OR: 3.76, p<0.001) and intrahepatic duct dilation (OR: 5.56, p<0.001) were highly significant predictors. However, only 37% of patients had a dilated CBD on ultrasonography. Ongoing elevation of LFT parameters, particularly ALP (AUC: 0.707, OR: 4.64, p<0.001) and ALT (AUC: 0.646, OR: 5.40, p<0.001), displayed a significant correlation with CBD stones.Conclusions
Ongoing (even if minor) elevations of liver function test parameters should prompt the need to exclude CBD stones even in the presence of a normal CBD diameter on ultrasonography. 相似文献44.
We have developed a general quenched-flow approach to study platelet function as early as 0.3 seconds after stimulation. Phosphorylation of 20- and 40-kd proteins has been analyzed during the first five seconds of platelet response to thrombin from 0.1 to 5.0 U/mL and compared with the progress of aggregation and serotonin secretion. The onset time for aggregation and phosphorylation of both proteins was less than one second, although with lowest (less than 0.5 U/mL) thrombin levels, a lag of up to 0.6 seconds occurred before 40K phosphorylation increased. The thrombin sensitivity of aggregation and 20K phosphorylation was approximately twice that of 40K phosphorylation, with Ka values of 0.51 and 0.53 v 1.10 U/mL, respectively. External calcium was necessary for maximal 20K phosphorylation, since EDTA inhibited this by 30%. The 40K phosphorylation was not affected by EDTA. Platelet activation by thrombin thus induced biochemical changes well before one second. The quenched-flow approach may help to reveal relationships between phospholipase activation, calcium fluxes, and protein phosphorylation during these early periods of platelet function. 相似文献
45.
A recombinant factor VIII A2 domain polypeptide quantitatively neutralizes human inhibitor antibodies that bind to A2 总被引:1,自引:0,他引:1
Human antibodies that inactivate coagulation factor VIII (fVIII), known as inhibitors, have been shown by immunoblotting or immunoprecipitation assays to bind predominantly to epitopes within the A2 and/or C2 domains of the fVIII protein. Because these assays simply measure antibody binding, a soluble recombinant polypeptide containing the fVIII A2 domain was used to develop a quantitative inhibitor neutralization assay for antibodies that bound only to A2 by immunoblotting assay. Antibodies from six of eight inhibitor plasmas were fully neutralized by A2 (> or = 90%), whereas two were only partially neutralized. These results established the fVIII inhibitor properties of anti-A2 antibodies. In immunoprecipitation assays, five of the eight inhibitors also had significant levels of anti-light-chain antibody. In one case, this light-chain antibody was shown to have inhibitor activity. Because it did not bind to the C2 domain, this antibody appears to define a new inhibitor epitope within the fVIII light chain. Another inhibitor, which was partially neutralized by A2, was not neutralized by the light chain, even though it contained anti- light-chain antibodies by immunoprecipitation assay. Our results show additional complexities of the immune response to fVIII. 相似文献
46.
47.
48.
49.
50.
Discoid lupus erythematosus is a manifestation of chronic cutaneous lupus erythematosus with a small risk of systemic involvement. In this review article, the role of predisposing factors such as haplotype, hormones, antibodies and sunlight are discussed. The clinical features, including variants and associations, and management options are presented. 相似文献